TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.03
+0.09 (1.82%)
Mar 4, 2026, 12:03 PM EST - Market open
TriSalus Life Sciences Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$12.00
Upside
+138.57%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +138.57% | Dec 17, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +118.69% | Mar 28, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +118.69% | Jan 24, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $10 | Buy | Initiates | $10 | +98.81% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +118.69% | Nov 15, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +118.69% | Nov 11, 2024 |
| Northland Capital Markets | Northland Capital Markets | Buy Initiates $13 | Buy | Initiates | $13 | +148.51% | Oct 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +98.81% | Sep 16, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +138.57% | Jun 27, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +138.57% | May 30, 2024 |
| JonesTrading | JonesTrading | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +218.09% | May 10, 2024 |